Karivax, founded in 2023 in San Diego, is at the forefront of vaccine innovation, specializing in the manufacturing of vaccines using self-assembling protein nanoparticle technology. This novel approach positions Karivax uniquely in the biotech industry, allowing for the development of a diverse range of therapeutics aimed at immunotherapy, cancer treatment, and advanced delivery agents. By leveraging cutting-edge science, Karivax is dedicated to transforming healthcare and offering new, effective treatments for various diseases.
Company Details
- Founded
- 2023
- Address
- San Diego, California, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://karivax.com/
- HQ
- SAN DIEGO, California
Karivax Questions
Karivax's website is https://karivax.com/
Karivax's LinkedIn profile is https://www.linkedin.com/company/karivax
Karivax's industry is
Biotechnology Research
Karivax's top competitors are
Venture Cooperative,
Generali Investments,
Global Evolution,
Soma Capital,
Conning,
Curveassure,
Prenosis,
Bank Of America Merrill Lynch,
Celesticus,
Fractionl.
Karivax's categories are Biotechnology Research
Karivax's founding year is 2023
